In this video:
Umesh Gupta, VP & Site Head – Operations, Glenmark Pharmaceuticals
Topic: A roadmap for value-driven, science-based hybrid business approach
Key Takeaway:
A shift from volume to value requires pharma companies to focus on patient-centricity, cost effectiveness, as well as process and product efficiency, among other factors to position themselves for long term success